Table 3 Provider Beliefs about Specific Diseases and Symptom Control, and Perceived Benefits to Patient Quality of Life, N (%)
From: A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers
Positive | Neutral | Negative | Don’t Know | |||
|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
Qualifying Medical Conditions (H) | ||||||
Cancer associated with severe/chronic pain, nausea or severe vomiting, or cachexia or severe wasting | 20 (32.3) | 29 (46.8) | 2 (3.2) | 0 (0.0) | 2 (3.2) | 9 (14.5) |
Glaucoma, missing = 1 | 3 (4.9) | 19 (31.2) | 7 (11.5) | 0 (0.0) | 2 (3.3) | 30 (49.2) |
HIV/AIDS | 4 (6.5) | 12 (19.4) | 12 (19.4) | 0 (0.0) | 4 (6.5) | 30 (48.4) |
Tourette Syndrome | 3 (4.8) | 13 (21.0) | 10 (16.1) | 1 (1.6) | 2 (3.2) | 33 (53.2) |
Amyotrophic Lateral Sclerosis (ALS) | 5 (8.1) | 12 (19.4) | 8 (12.9) | 0 (0.0) | 3 (4.8) | 34 (54.8) |
Seizures, including those characteristic of Epilepsy | 8 (12.9) | 18 (29.0) | 8 (12.9) | 1 (1.6) | 2 (3.2) | 25 (40.3) |
Severe and persistent muscle spasms, including those characteristic of Multiple Sclerosis | 8 (12.9) | 23 (37.1) | 7 (11.3) | 0 (0.0) | 3 (4.8) | 21 (33.9) |
Inflammatory bowel disease, including Crohn’s disease | 3 (4.8) | 8 (12.9) | 12 (19.4) | 1 (1.6) | 5 (8.1) | 33 (53.2) |
Terminal illness, with a probable life expectancy of less than one year | 14 (22.6) | 23 (37.1) | 4 (6.5) | 1 (1.6) | 2 (3.2) | 18 (29.0) |
Intractable pain | 14 (22.6) | 28 (45.2) | 3 (4.8) | 2 (3.2) | 4 (6.5) | 11 (17.7) |
Post-Traumatic Stress Disorder, missing = 2 | 5 (8.3) | 10 (16.7) | 11 (18.3) | 1 (1.7) | 2 (3.3) | 31 (51.7) |
Obstructive Sleep apnea | 1 (1.6) | 2 (3.2) | 13 (21.0) | 4 (6.5) | 8 (12.9) | 34 (54.8) |
Autism | 2 (3.2) | 1 (1.6) | 11 (17.7) | 4 (6.5) | 7 (11.3) | 37 (59.7) |
Symptoms (H) | ||||||
Pain | 12 (19.4) | 37 (59.7) | 2 (3.2) | 0 (0.0) | 4 (6.5) | 7 (11.3) |
Seizures | 10 (16.1) | 20 (32.3) | 9 (14.5) | 2 (3.2) | 2 (3.2) | 19 (30.7) |
Nausea and/or vomiting | 9 (14.5) | 33 (52.3) | 5 (8.1) | 3 (4.8) | 2 (3.2) | 10 (16.1) |
Muscle spasms | 4 (6.5) | 20 (32.3) | 15 (24.2) | 0 (0.0) | 3 (4.8) | 20 (32.3) |
Anxiety | 8 (12.9) | 28 (45.2) | 6 (9.7) | 6 (9.7) | 4 (6.5) | 10 (16.1) |
Depression | 3 (4.8) | 8 (12.9) | 7 (11.3) | 20 (32.3) | 11 (17.7) | 13 (21.0) |
Sleeplessness | 4 (6.5) | 17 (27.4) | 12 (19.4) | 3 (4.8) | 6 (9.7) | 20 (32.3) |
Weight loss | 5 (8.1) | 7 (11.3) | 12 (19.4) | 6 (9.7) | 10 (16.1) | 22 (35.5) |
Tics | 3 (4.8) | 13 (21.0) | 9 (14.5) | 2 (3.2) | 2 (3.2) | 33 (53.2) |
Quality of Life (E) | ||||||
Physical functioning | 4 (6.5) | 10 (16.1) | 18 (29.0) | 10 (16.1) | 4 (6.5) | 16 (25.8) |
Energy level | 2 (3.2) | 4 (6.5) | 15 (24.2) | 9 (14.5) | 10 (16.1) | 22 (35.5) |
Mood | 3 (4.8) | 10 (16.1) | 17 (27.4) | 10 (16.1) | 5 (8.1) | 17 (27.4) |
Enjoyment of life | 3 (4.8) | 15 (24.2) | 18 (29.0) | 5 (8.1) | 3 (4.8) | 18 (29.0) |
Social engagement (visiting with friends and family), missing = 1 | 4 (6.6) | 10 (16.4) | 16 (26.2) | 9 (14.8) | 3 (4.9) | 19 (31.2) |
Ability to work | 2 (3.2) | 9 (14.5) | 12 (19.4) | 11 (17.7) | 8 (12.9) | 20 (32.3) |
Sense of hope, missing = 1 | 4 (6.6) | 11 (18.0) | 14 (23.0) | 9 (14.8) | 4 (6.7) | 19 (31.2) |